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RESEARCH ARTICLE

REV-ERBa mediates complement
expression and diurnal regulation of
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Abstract The circadian clock regulates various aspects of brain health including microglial and
astrocyte activation. Here, we report that deletion of the master clock protein BMAL1 in mice
robustly increases expression of complement genes, including C4b and C3, in the hippocampus.
BMAL1 regulates expression of the transcriptional repressor REV-ERBa, and deletion of REV-ERBa
causes increased expression of C4b transcript in neurons and astrocytes as well as C3 protein
primarily in astrocytes. REV-ERBa deletion increased microglial phagocytosis of synapses and
synapse loss in the CA3 region of the hippocampus. Finally, we observed diurnal variation in the
degree of microglial synaptic phagocytosis which was antiphase to REV-ERBa expression. This daily
variation in microglial synaptic phagocytosis was abrogated by global REV-ERBa deletion, which
caused persistently elevated synaptic phagocytosis. This work uncovers the BMAL1-REV-ERBa axis
as a regulator of complement expression and synaptic phagocytosis in the brain, linking circadian
proteins to synaptic regulation.
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Introduction
The circadian clock orchestrates 24 hr rhythms in various cellular processes through transcriptionaltranslational feedback loops in most cells of the body (Takahashi, 2017). At the core of the clock’s
positive limb is the bHLH-PAS transcription factor BMAL1, which heterodimerizes with CLOCK or
NPAS2 to drive the transcription of large sets of clock-controlled genes (Mohawk et al., 2012).
BMAL1 transcriptional targets include the negative limb feedback regulator CRY and PER proteins,
as well as REV-ERBa and b, nuclear receptors which can also inhibit the actions of the positive limb
(Preitner et al., 2002; Retnakaran et al., 1994). Disruption of this circadian machinery is associated
with various pathophysiological states including cancer, diabetes, and neurodegeneration
(Everett and Lazar, 2014; Musiek and Holtzman, 2016; Sulli et al., 2018). Deletion of BMAL1
abrogates circadian clock function and leads to an ~80% decrease in REV-ERBa expression in the
brain (Musiek et al., 2013). REV-ERBa functions as a transcriptional repressor in many tissues and
has been implicated in regulation of metabolism and inflammation (Everett and Lazar, 2014). Previous work from our group shows that deletion of BMAL1 or its downstream target REV-ERBa causes
neuroinflammation and impaired brain functional connectivity (Griffin et al., 2019; Musiek et al.,
2013). Diminished BMAL1 and REV-ERBa expression have also been described in mouse models of
Alzheimer’s disease (AD)(Lee et al., 2020; Stevanovic et al., 2017). In AD, memory-associated, synapse-rich regions such as the hippocampus are affected early in the disease course (Braak et al.,
2006). Synaptic loss also precedes neuronal death in neurodegeneration (Selkoe, 2002). Circadian
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dysfunction is also a well-described symptom of AD and other neurodegenerative diseases
(Musiek and Holtzman, 2016; Videnovic et al., 2014). Therefore, elucidating the how clock proteins regulate synaptic health is an important step in understanding the connection between circadian dysfunction and neurodegeneration.
A wealth of recent studies have emphasized the critical role of the complement system of the
brain in regulating neuroinflammation and synaptic integrity. Synapses labeled with the opsonins
C1q and C3 (Stevens et al., 2007) were first described to be pruned by microglia during development (Schafer et al., 2012). C4 protein, encoded by the mouse C4b gene, also contributes to synaptic pruning by microglia in vivo (Sekar et al., 2016; Comer et al., 2020). Complement-dependent
microglial synaptic pruning has also been implicated in the pathogenesis of neurodegenerative and
neuropsychiatric diseases (Hong et al., 2016; Litvinchuk et al., 2018; Sekar et al., 2016;
Werneburg et al., 2020). Microglial activation is subject to circadian regulation (Fonken et al.,
2015; Hayashi et al., 2013), and we have previously described that deletion of BMAL1 or REVERBa can induce microglial activation (Griffin et al., 2019; Musiek et al., 2013). Given the roles of
the clock in neurodegeneration and microglial activation, we explored a potential role of the core
clock in regulating synaptic health. Herein, we establish a link between the BMAL1-REV-ERBa axis,
complement expression, and microglial synaptic pruning in the hippocampus.

Results
Disruption of the BMAL1-REV-ERBa axis induces complement
upregulation in multiple brain cell types
While analyzing our previously published transcriptomic dataset from global Bmal1 knockout
(BMKO) hippocampal tissue, we observed a striking upregulation of several complement transcripts,
in particular C4b and C3 (Griffin et al., 2019), two genes which are critical for synaptic phagocytosis
(Figure 1A). Other complement-related transcripts including C1qc, C1qb, C1qa, and C1ra were also
increased in BMKO hippocampus (Figure 1A). Analysis of second published microarray dataset from
our group which was derived from cerebral cortex samples from brain-specific Bmal1 KO mice (Nestin-Cre;Bmal1f/f) mice (Lananna et al., 2018) also revealed specific upregulation of C4b, but less so
for other complement factors (Figure 1A). C4b was similarly increased in cerebral cortex samples
from 4mo tamoxifen-inducible global BMAL1 KO mice (CAG-CreERT2;Bmal1f/f) in which Bmal1 was
deleted at 2mo, demonstrating that this is not a developmental phenomenon (Figure 1—figure supplement 1).
To determine the cell type(s) in which BMAL1 deletion induces complement gene expression, we
examined cerebral cortex tissue from pan-neuronal-(CamK2a-iCre;Bmal1fl/fl) (Izumo et al., 2014),
astrocyte- (Aldh1l1-CreERT2;Bmal1fl/fl) (Lananna et al., 2018), and microglia-specific (Cx3cr1-CreERT2;
Bmal1fl/fl) (Parkhurst et al., 2013) BMAL1 knockout mice. Both astrocyte- and microglia-specific
Bmal1 KO mice were treated with tamoxifen at 2mo and harvested 2 months later. Notably, C4b
mRNA was strongly induced in the neuron-specific Bmal1 KO mice, while C3 was not (Figure 1B).
C4b was also induced to a lesser degree in astrocyte-specific Bmal1 KO mice, although C3 was not
(Figure 1C). Under basal conditions, neither C4b nor C3 was induced in microglia specific Bmal1 KO
mice (Figure 1D). Deletion of Bmal1 in primary Bmal1fl/fl neuron cultures via infection with an AAV8Cre viral vector (versus AAV8-eGFP control) suppressed the BMAL1 transcriptional target Nr1d1
(which encodes REV-ERBa) by 85% and induced C4b expression but caused no increase in C3
(Figure 1E). Bmal1 deletion also increased expression of Fabp7 (Figure 1E), a known target of REVERBa-mediated transcriptional repression (Schnell et al., 2014). As REV-ERBa mRNA (Nr1d1) is also
suppressed by ~80% in the brain following brain-specific Bmal1 deletion (Figure 1—figure supplement 1), our data suggested that the upregulation of C4b gene expression observed with loss of
BMAL1 could be mediated by transcriptional de-repression as consequence of downstream REVERBa loss. Accordingly, global deletion of REV-ERBa caused striking increases in C4b, C3, and other
complement transcripts in the hippocampus as assessed by microarray analysis (Figure 1A) and confirmed in separate samples by qPCR (Figure 1F). Increased C3 protein expression was observed in
activated astrocytes (Figure 1G, Figure 1—figure supplement 2) in the hippocampus of 5mo REVERBa KO (RKO) mice. There was less overlap of C3 expression and the microglial marker Iba1
(Figure 1H), although microglial C3 expression did increase in RKO brain (Figure 1—figure
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Figure 1. REV-ERBa regulates complement expression in multiple cell types downstream of BMAL1. (A) Relative expression of complement-related
transcripts taken from microarray analysis performed on hippocampus from 5mo REV-ERBa KO (RKO) and littermate WT mice (N = 3/genotype), global
BMAL1 KO mice (BKO, N = 2), or 12mo Nestin-Cre;Bmal1f/f mice (NCre+), and littermate Cre- controls (NCre-, N = 3/group). Colors indicate fold
change versus control. (B) qPCR analysis of 11 month old control (Cre-) and neuron-specific Bmal1 KO mice (Camk2a-iCre+;Bmal1fl/fl) for complement
genes (N = 3–4/group). (C) qPCR analysis of control (Cre-) and astrocyte-specific Bmal1 KO mice (Aldh1l1-CreERT2+;Bmal1fl/fl) for complement genes
(N = 5 mice/group). (D) qPCR analysis of control (Cre-) and microglia-specific Bmal1 KO mice (Cx3cr1- CreERT2+;Bmal1fl/fl) for complement genes
(N = 4–8/group). For C and D, all mice (Cre- or +) were treated with tamoxifen at 2mo and harvested at 4mo, mixed sexes, Cre- littermates were used
as controls. (E) qPCR analysis of mRNA from primary cortical neurons isolated from Bmal1fl/fl mice, treated with AAV8-GFP (control) or AAV8-Cre (n = 4–
5 wells/group). (F) qPCR analysis of WT or RKO mouse hippocampal tissue for complement genes (N = 5–10 mice/group). (G) Representative 40X
maximum intensity projections of GFAP and C3 staining as well as the merged channel in the hippocampus of 5mo WT or RKO mice and the
associated normalized volumes for C3-GFAP staining (n = 8 mice, N = 4/group). (H) Representative 40X maximum intensity projections of Iba1 and C3
staining as well as the merged channel in the hippocampus of 5mo WT or RKO mice. Scale bar = 100 mm. *p<0.05 **p<0.01 ***p<0.001, ns = not
significant, by two-tailed T-test with Welch’s correction.
The online version of this article includes the following source data and figure supplement(s) for figure 1:
Source data 1. Data from the graphs depicted in Figure 1.
Figure supplement 1. Brain-specific or post-natal Bmal1 deletion cause early induction of C4b.
Figure supplement 2. C3 colocalization with astrocytes and microglia in RKO brain.

supplement 2). The finding that Bmal1 deletion in neurons (and to a less degree astrocytes) induces
C4b mRNA but that C3 only increases in global BMKO and RKO mice suggests that REV-ERBa
directly represses C4b expression in neurons and astrocytes, but the induction of C3 in both BMKO
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and RKO brain is likely secondary to a multicellular inflammatory glial activation which occurs over
time.

REV-ERBa regulates microglial synaptic engulfment
We previously demonstrated that global REV-ERBa deletion induced microglial activation in vivo
(Griffin et al., 2019). Given those results and the observation of increased C4b and C3 expression in
RKO brains, we examined the possibility that these changes would enhance synaptic phagocytosis in
4–6mo RKO mice. We primarily focused on the mossy fiber synapses in the CA2/3 region of the hippocampus, as these large synapses (thorny excrescences) can easily be stained and imaged using
standard confocal microscopy. Triple-labeling of tissue sections was performed with antibodies
against synaptophysin (a marker of presynaptic neuronal terminals – Figure 2A), CD68 (a microglial
lysosome marker – Figure 2B) and Iba1 (to define microglial cell bodies and processes – Figure 2C).
CD68 was used to ensure that the colocalized synaptic material was actually within the microglia
phagosome. 3D reconstructions were made and total volumes of engulfed synaptic material were
calculated (Figure 2D, Figure 2—figure supplement 1). In the RKO microglia, we observed synaptic
material in the microglial process and cell body (Figure 2Eii, Eiii), whereas WT microglia only had
engulfed synaptic material in the cell body (Figure 2Ei). In all, we noted a 13.6-fold increase in
engulfed synaptic material in the hippocampus of RKO mice compared to their WT littermates
(Figure 2F).
To corroborate these results, we also performed large area scanning electron microscopy (SEM)
experiments of the CA3 region of 4–6mo WT and RKO mice. Using this method, we visually confirmed an increased number of presynaptic terminals within or in contact with microglia in the hippocampus of RKO mice compared to WT (Figure 2G and H, 2H(i-v), 2I). We also noted downregulation
in the expression of the Sirpa gene in our RKO mice which codes for the protein SIRPa (Figure 1A).
SIRPa was recently described as a surface receptor on microglia that serves as a receptor for a ‘donot-eat-me’ signal (Lehrman et al., 2018). Notably, Sirpa was not downregulated in Nestin-CreBmal1 KO mice (Figure 1A), which have normal microglial BMAL1 and REV-ERBa expression, suggesting a possible cell-autonomous effect of REV-ERBa on microglial Sirpa expression. Taken
together, our results suggest that REV-ERBa deletion induces synaptic engulfment.

CA3 synapses are reduced by REV-ERBa deletion
Following our observations of increased synaptic phagocytosis in the RKO mice, we investigated the
status of the synapses in the CA3 region of the hippocampus. Synapses were double labeled by
using the presynaptic marker synaptophysin and the postsynaptic marker homer1, followed by confocal imaging. In RKO mice, we observed a significant decrease in the synaptic volume in the CA3
region of the hippocampus by synaptophysin staining (Figure 3A), homer1 staining (Figure 3B), and
their colocalization (Figure 3C) compared to their WT littermates. To further confirm these results,
we counted synapses in large area SEM images from the stratum lucidum of WT or RKO mice. Again,
we noted a decrease in the number of synapses in the RKO mouse CA3 by SEM, as compared to
their WT littermates (Figure 3D).
To ensure that our observations were not due purely to changes in synaptophysin protein expression in the presynaptic terminal, synapses were also stained with a second presynaptic marker, synaptoporin, and quantified. Synaptoporin was used because it is enriched in the mossy fiber synapses
of the hippocampus (Singec et al., 2002). Again, we observed a similar decrease in synaptic volume
in CA3 of RKO mice compared to their WT littermates using synaptoporin staining (Figure 3E). Interestingly, we did not observe significant differences in synaptic volumes between WT and RKO mice
in the CA1 region of the hippocampus (Figure 2—figure supplement 1), suggesting that some terminals may be more susceptible to loss than others. To determine whether the loss in synapses was
due to a loss of neuronal cell bodies, we quantified the volume and width of neuronal nuclei of the
dentate gyrus, which project to CA3, via NeuN staining. We found no significant difference between
the neuronal nuclear width or volumes of the dentate gyrus between the WT and RKO mice (Figure 3—figure supplement 2). Moreover, we did not observe any change in 3-nitrotyrosine staining
in the dentate gyrus, suggesting there is no increase in neuronal nitrosative stress in RKO mice (Figure 3—figure supplement 3). Taken together, our data suggest that deletion of REV-ERBa results
in robust synaptic loss in the CA3 region without obvious neuronal loss.
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Figure 2. REV-ERBa deletion increases synaptic phagocytosis in the CA3 region of the hippocampus. (A-C) Image of synaptophysin (A), colocalized
synaptophysin/CD68 (B), and colocalized synaptophysin/CD68/Iba1 (C) within microglia in the CA3 region of 4–6mo WT or RKO mice sacrificed at
11AM. D. Representative 3D surface rendering of microglia showing engulfed presynaptic material in lysosomes. (E) Magnified inset from WT (Ei) and
RKO (Eii, iiii) microglia showing synaptophysin within CD68+ phagosomes. (F) Quantification of the normalized Iba1-CD68-Synaptophysin volumes from
microglia in the CA3 region of the hippocampus of 4–6mo WT and RKO mice. Each point is the average of 3 sections from one mouse, N = 15 WT and
12 RKO mice. (G-H) Annotated, representative scanning electron micrographs of microglia in the CA3 of WT (G, pseudocolored Cyan) or RKO (H,
pseudocolored Royal blue) mice sacrificed at 11AM with magnified inset pictures of engulfed presynaptic terminals (pseudocolored orange) in Hi and
presynaptic terminals in contact with microglia (pseudocolored green) in Hii, Hiii, and Hiv. (I) Quantification of presynaptic terminals in contact with or
engulfed by microglia in the CA3 of WT or RKO mice. Each point represents averaged data from a single mouse, N = 4 mice/genotype. In I, 3–15
microglia were counted per mouse. Scale bar for A–D = 5 mm. **p<0.01,***p<0.001 by two-tailed T-test with Welch’s correction.
The online version of this article includes the following source data and figure supplement(s) for figure 2:
Source data 1. Data from the graphs depicted in Figure 2.
Figure supplement 1. Confirmation of antibody colocalization with orthogonal view.

Time-of-day variation in microglial phagocytosis is regulated by REVERBa
In mouse cerebral cortex and ventral midbrain, REV-ERBa displays daily oscillation in mRNA level
with its peak around zeitgeber time (ZT) eight and its trough around ZT20 (Chung et al., 2014). We
have also previously described oscillations in microglial activation, with low activation at ZT5 and
high activation at ZT17 (Griffin et al., 2019). Consequently, we investigated microglial synaptic
engulfment at these times of day. WT (C57BL/6) and RKO mice were sacrificed ZT17 (11PM), and
hippocampal sections were triple labeled with Iba1, CD68, and synaptophysin, and compared to
those sacrificed at ZT5 (11AM, shown in Figure 2). Microglia from the CA3 region of the hippocampus in WT mice sacrificed at ZT17 showed significantly more engulfed presynaptic protein than those
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at ZT5 (Figure 4A–C). When compared to the WT mice, RKO mice harvested at ZT5 and 17 showed
a persistently increased level of synaptic engulfment in microglia, but with no time-of-day variation
(Figure 4C), suggesting that daily oscillations in REV-ERBa may mediate rhythms in microglial synaptic phagocytosis. To further establish these findings, we used large area SEM to count the number of
presynaptic terminals in contact with or within microglia at ZT17, and compared to mice harvested
at ZT5 (shown in Figure 2G–H). In that experiment, we also noted a higher number of presynaptic
terminals in contact with and within the microglia at ZT17 (Figure 4D–F). As a final confirmation of
this finding, we injected Cx3cr1GFP mice, which express GFP in microglia (Jung et al., 2000), with an
AAV-Camk2a-mCherry viral vector in the retrospenial cortex, to express mCherry in neurons. 4
weeks later, we collected brain samples at ZT5 and 17, and calculated the volume of mCherry+
material in individual GFP+ microglia. We observed that microglia at 11PM (ZT17) showed a qualitative increase in mCherry engulfment as compared to those at 11AM (ZT5) (Figure 4—figure supplement 1). Overall, our data establish a REV-ERBa-dependent rhythm for the engulfment of neuronal
materials by microglia in the brain.

Discussion
The current study shows that loss of the circadian protein BMAL1 causes upregulation of complement gene C4b in neurons and astrocytes, as well as increase astrocytic C3 expression, changes
which are recapitulated by loss of downstream REV-ERBa-mediated transcriptional repression. Deletion of REV-ERBa leads to microglial activation, increased C4b and C3 mRNA expression, increased
astrocyte C3 protein expression, and increased microglial synaptic phagocytosis in CA3 region of
the hippocampus. Finally, we demonstrate a time-of-day variation in synaptic phagocytosis in the
hippocampus of WT mice which is antiphase to REV-ERBa levels and lost after REV-ERBa deletion.
Our findings suggest that the BMAL1-REV-ERBa axis regulates daily rhythms in synaptic phagocytosis, and that loss of REV-ERBa de-represses complement gene expression and locks the brain in a
pro-phagocytic state.
The mechanisms by which BMAL1 deletion leads to increased C4b expression are complex and
multicellular but likely depend on REV-ERBa, although contributions of other pathways cannot be
excluded. REV-ERBa expression is decreased by ~85% following BMAL1 deletion, and REV-ERBa
deletion phenocopies the complement gene expression increases seen in Bmal1 KO brain. Indeed, it
is well established that REV-ERBa functions as a transcriptional repressor (Harding and Lazar,
1995). Loss of REV-ERBa-mediated repression is a general mechanism governing increased transcript expression following BMAL1 deletion - as evidenced by strong upregulation of the REV-ERBa
repression target Fabp7 following BMAL1 deletion (Schnell et al., 2014). Notably, we queried an
existing REV-ERBa ChIP-seq database from brain tissue (Zhang et al., 2015), and did not find any
peaks corresponding to C4b. However, REV-ERBa is known to regulate transcription not only by
direct binding to RORE and RevDR2 sites but also by regulating enhancer function and eRNA
expression to alter gene expression in trans (Lam et al., 2013), and by altering chromatin looping
(Kim et al., 2018). Thus, it is likely that REV-ERBa regulates C4b expression in one of these alternative ways which is not apparent by typical ChIP-seq. Tissue-specific deletion of BMAL1 shows that
this BMAL1-REV-ERBa axis controls C4b expression in neurons and astrocytes, but not in microglia.
Recent single-nucleus RNAseq data suggests that C4b is prominently expressed in oligodendrocytes
(Zhou et al., 2020). However, we have not yet evaluated the effect of BMAL1 or REV-ERBa deletion
on C4b in this cell type. Presumably, C4b expression is low in neurons and astrocytes under normal
conditions but is increased by BMAL1 or REV-ERBa deletion. Work from the Stevens and McCarroll
labs identified C4b expression in neurons which then tagged synapses and facilitated synaptic pruning, and showed that deletion of C4b prevents accumulation of C3 protein at synapses, as C4 protein in upstream of C3 activation in the classical complement pathway (Sekar et al.,
2016). Moreover, neuronal overexpression of mouse C4 can drive microglial synaptic phagocytosis
and cause functional connectivity deficits in mice (Comer et al., 2020), two phenotypes observed by
us in RKO mice.
Bmal1 KO and RKO mice at 5–6mo also show an increase in C3 transcript and C3 protein in astrocytes. However, tissue-specific Bmal1 deletion in neurons or astrocytes causes pronounced C4b
increases but no C3 increases, suggesting that C3 expression in astrocytes and microglia is a secondary response to increased neuroinflammation in aged global Bmal1 KO or RKO mouse brain. Global
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Figure 3. REV-ERBa deletion induces synapse loss in the CA3 region. (A) 60X representative maximum intensity projections showing synaptophysin
staining in the CA3 of 4–6mo WT and RKO mice harvested at 11AM with the associated normalized volume quantification (N = 15 WT and 12 RKO
mice). (B) 60X representative maximum intensity projections showing homer1 staining in CA3 of 4–6mo WT and RKO mice with the associated
normalized volume quantification. (C) 60X representative maximum intensity projections showing colocalized synaptophysin and homer1 staining in CA3
of 4–6mo WT and RKO mice with the associated normalized volume quantification. (D) Representative scanning electron micrographs of synapses
(presynaptic terminal pseudocolored in red, postsynaptic terminal in green), as well as the associated synapse counts for 4–6mo WT and RKO mice.
N = 4 mice/genotype, with each point representing the average of 32–56 images counted per mouse. (E) 60X representative maximum intensity
projections showing synaptoporin staining in the CA3 of 4–6mo WT and RKO mice. Colocalization with nuclei (DAPI) shown in lower images. (F) Highmagnification images of synaptoporin staining of CA3 synapses from WT and RKO mice to show detail. (G). Normalized volume quantification of CA3
synaptoporin signal (N = 6 mice/genotype). *p<0.05, **p<0.01, ****p<0.0001 by two-tailed T-test with Welch’s correction. In all panels, each point
represent the average of three sections from a single mouse. Scale bar = 50 mm in all panels except D.
The online version of this article includes the following source data and figure supplement(s) for figure 3:
Source data 1. Data from the graphs depicted in Figure 3.
Figure supplement 1. REV-ERBa deletion does not induce synapse loss in CA1.
Figure supplement 2. No change in dentate gyrus neuronal layer volume or width in RKO mice.
Figure supplement 3. No change in dentate gyrus neuronal 3-nitrotyrosine in RKO mice.

inducible Bmal1 KO mice also do not show C3 induction at 2mo post-tamoxifen (despite high C4b
expression), as these mice have not developed a full neuroinflammatory response at that age. Our
data suggest that full induction of C3 in BMKO and RKO brain requires a multicellular, time-dependent inflammatory response involving microglia, as Nestin-Cre-Bmal1 KO mice, which have Bmal1
deletion in neurons and astrocytes but not microglia, have increased C4b expression but normal C3
and Sirpa levels. We have previously shown that REV-ERBa deletion increases microglial activation,
Traf2 expression, and increased NFkB signaling (Griffin et al., 2019). Thus, REV-ERBa loss in microglia may be necessary, but not sufficient, to induce astrocyte C3 expression. Indeed, activated microglia can readily induce astrocyte C3 in response to LPS (Liddelow et al., 2017). NFkB signaling has
also been shown to increase C3 expression and release from astrocytes (Lian et al., 2015). Functionally, C4 loss is associated with less synaptic tagging with C3 and thus less synaptic pruning
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Figure 4. Time-of-day oscillation in microglial phagocytosis. Representative 3D surface rendering of Iba1, CD68 and synaptophysin in Iba1+ microglia
from 6mo WT mice sacrificed at (A) 11AM or (B) 11PM with inset. Scale bar = 5 mm. (C) The normalized volume quantification of Iba1-CD68Synaptophysin showing microglial phagocytosis of synapses in WT and RKO mice harvested at 11AM or 11PM (N = 4–12 mice/group). Note that the
data from the WT AM and RKO AM groups was shown in Figure 2F. (D-F) Representative scanning electron micrographs of microglia in the CA3 of WT
mice sacrificed at 11AM (D) or 11PM (E) as well as a high-magnification inset of presynaptic terminals within the microglia (Ei). (F) Quantification of
presynaptic terminals in contact with or engulfed by microglia in WT mice sacrificed at 11AM or 11PM. N = 4 mice/timepoint, 4–10 fields of view each.
Note that the WT AM group was shown in Figure 2I. *p<0.05, ***p<0.001 by two-tailed T-test with Welch’s correction.
The online version of this article includes the following source data and figure supplement(s) for figure 4:
Source data 1. Data from the graphs depicted in Figure 4.
Figure supplement 1. Viral injection approach for diurnal variation in synaptic pruning.
Figure supplement 2. Diagram depicting multicellular contribution to synaptic phagocytosis by REV-ERBa.

(Sekar et al., 2016), suggesting that C4 expression can drive C3-dependent synapse pruning. Additionally, we noted that REV-ERBa regulated the microglial ‘do-not-eat-me’ signal Sirpa (encoding
SIRPa) in our microarray data. Loss of inhibitory signaling from SIRPa makes microglia more likely to
prune synapses, since SIRPa is primarily expressed on microglia in the CNS (Lehrman et al., 2018;
Zhang et al., 2014). Therefore, our data suggest that de-repression of C4b in neurons and Traf2 in
astrocytes and microglia, as well as diminished Sirpa expression in microglia, lead to a ‘perfect
storm’ of complement expression and microglial activation that promotes synaptic phagocytosis
(Figure 4—figure supplement 2). Detailed future studies using combinations of tissue-specific REVERBa mutants will be needed to elucidate this complex interaction.
We focused on the CA2/3 mossy fiber synaptic boutons because they are large and easily labeled
with synaptic vesicle markers – in this case synaptoporin and synaptophysin (Grosse et al., 1998).
However, we did not observe synapse loss in the CA1 region, which may represent a regional variability in BMAL1-REV-ERBa mediated synaptic pruning. Certainly, it is possible that certain synapses
are more susceptible to pruning than others, and this should be addressed in the future. We cannot
exclude the possibility that REV-ERBa deletion causes neuronal damage, which elicits microglial
phagocytosis of dysfunctional synapses. Indeed, neuronal C4b upregulation could be a damage
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signal, although this has not been established. However, the absence of neuronal cell body loss or
increased 3-nitrotyrosine in the dentate gyrus of RKO mice shows that there is no overt neurodegenerative response. These dentate gyrus granule cells give rise to the mossy fiber boutons in the CA3
(Scharfman and Myers, 2012), which are clearly decreased in RKO mice. Thus, the effect of REVERBa appears to be specific to the synapses.
Herein, we establish REV-ERBa as a regulator of microglial synaptic phagocytosis. However, we
have previously reported that time-of-day changes in microglial morphology were abrogated by
REV-ERBa deletion (Griffin et al., 2019). Herein, we observed that microglia engulfed more CA3
synapses at 11PM (ZT17) than at 11AM (ZT5). This was evident by both immunofluorescence and by
electron microscopy. REV-ERBa deletion abrogated this time-of-day variation in synaptic protein
phagocytosis, as RKO mice had high levels of phagocytosis at both timepoints. This data parallels
our previous findings with microglial morphologic changes and suggests that REV-ERBa mediates
daily changes in the degree of microglial synaptic engulfment, with both microglial activation and
synaptic phagocytosis increasing when REV-ERBa levels are low. Accordingly, REV-ERBa deletion
appears to lock the system in one of the extremes of this naturally occurring diurnal variation.
Several studies have illustrated the complexity of the interplay between cellular rhythms and sleep
in regulating synapses in the brain (Bellesi et al., 2017; Brüning et al., 2019; Noya et al., 2019).
RKO have subtle alterations in sleep but show grossly normal circadian rhythms in activity and are
not sleep deprived (Mang et al., 2016), suggesting that sleep alteration is a possible but less likely
contributor to the synaptic phenotypes in RKO mice. A previous study in the rat prefrontal cortex
found that synaptic elimination was highest at ZT0 (Choudhury et al., 2020). While we did not
examine ZT0, it is worth noting that these studies were done in the prefrontal cortex suggesting
potential brain region-specific pruning patterns by time of day. Heterogeneity in synaptic pruning
has already been described, with areas such as the cerebellum exhibiting greater microglial phagocytic capacity (Ayata et al., 2018). Future work will have to explore the patterns in microglial phagocytosis across more brain regions.
This work has clear implications for neurodegenerative and neuropsychiatric diseases, which have
been linked to circadian disruption as well as complement dysregulation and synapse loss. Since
REV-ERBa is a nuclear receptor with available small-molecule ligands (Solt et al., 2012), our findings
suggest that it could be a therapeutic target for neurological and psychiatric disease. In previous
studies in the brain, activation of REV-ERBs appears to suppress microglial cytokine production
(Griffin et al., 2019) while inhibition of REV-ERBs can induce microglial amyloid-beta uptake and
decrease plaque burden in mice (Lee et al., 2020). Effects on synaptic engulfment should be considered as REV-ERB-based therapeutics are developed.

Materials and methods
Key resources table
Reagent type
(species) or resource

Designation

Source or reference

Identifiers

Additional information

Antibody

Gfap (Rabbit polyclonal)

Dako/Agilent

Cat# Z0334
RRID:AB_10013382

IF (1:2500)

Antibody

C3 (Rat monoclonal)

Novus

Cat# NB200-540
RRID:AB_10003444

IF (1:500)

Antibody

Iba1 (Goat polyclonal)

Abcam

Cat# ab5076
RRID:AB_2224402

IF (1:500)

Antibody

Synaptophysin
(Mouse monoclonal)

Abcam

Cat# 8049
RRID:AB_2198854

IF (1:100)

Antibody

Homer1
(Rabbit polyclonal)

Synaptic Systems

Cat# 160 003
RRID:AB_887730

IF (1:500)

Antibody

CD68 (Rat monoclonal)

BioRad

Cat# MCA1957
RRID:AB_322219

IF (1:250)

Antibody

NeuN
(Mouse monoclonal)

EMD/Millipore

Cat# MAB377
RRID:AB_2298772

IF (1:1000)

Continued on next page
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Continued
Reagent type
(species) or resource

Designation

Source or reference

Identifiers

Additional information

Antibody

3-Nitrotyrosine
(Rabbit polyclonal)

Millipore/
Sigma

Cat# AB5411
RRID:AB_177459

IF (1:1000)

Genetic reagent (mouse)

Bmal1 (Arntl)-/- mice

Jackson Labs

Cat# 009100 B6.129-Arntltm1Bra/J
RRID:IMSR_JAX:009100

Genetic reagent (mouse)

Bmal1(flox/flox) mice

Jackson Labs

Cat# 007668-B6.129S4
(Cg)Arntltm1Weit/J
RRID:IMSR_JAX:007668

Genetic reagent (mouse)

Nr1d1-/- mouse

Jackson Labs

Cat# 018447- B6.CgNr1d1tm1Ven/LazJ
RRID:IMSR_JAX:018447

Rev-Erba KO mouse line

Genetic reagent (mouse)

Nestin-Cre mice

Jackson Labs

Cat# 003771- B6.CgTg(Nes-cre)1Kln/J
RRID:IMSR_JAX:003771

Nestin-Cre line crossed
to Bmal1f/f

Genetic reagent (mouse)

Aldh1l1-CreERT2 mice

Jackson Labs

Cat# 031008B6N.FVB-Tg(Aldh1l1cre/ERT2)1Khakh/J
RRID:IMSR_JAX:031008

Aldh1l1-CreER line crossed
to Bmal1f/f

Genetic reagent (mouse)

Cx3cr1-CreERT2 mice

Jackson Labs

Cat# 021160B6.129P2(Cg)Cx3cr1tm2.1
(cre/ERT2)Litt/WganJ
RRID:IMSR_JAX:021160

Cx3cr1-CreER line crossed
to Bmal1f/f

Genetic reagent (mouse)

CAG- CreERT2 mice

Jackson Labs

Cat# 004682-B6.
Cg-Tg(CAG-cre/Esr1*)5Amc/J
RRID:IMSR_JAX: 004682

CAG-CreER line crossed
to Bmal1f/f

Genetic reagent (mouse)

Camk2a-iCre
BAC TG mice

Obtained from
Dr. J. Takahashi.
Created by
Dr. Gunther Schutz

MGI symbol:
Tg(Camk2a-cre)2Gsc
RRID:MGI:4457404

BAC Tg Camk2a-iCre mouse

Sequence-based reagent

Actb (mouse)

Thermo-Fisher/Life
Technologies

Taqman qPCR primer
Cat#: Mm02619580_g1

Sequence-based reagent

Nr1d1 (mouse)

Thermo-Fisher/Life
Technologies

Taqman qPCR primer
Cat#: Mm00520708_m1

Sequence-based reagent

C4b (mouse)

Thermo-Fisher/Life
Technologies

Taqman qPCR primer
Cat#: Mm00437893_g1

Sequence-based reagent

C3 (mouse)

Thermo-Fisher/Life
Technologies

Taqman qPCR primer
Cat#: Mm01232779_m1

Sequence-based reagent

Fabp7 (mouse)

Thermo-Fisher/Life
Technologies

Taqman qPCR primer
Cat#: Mm00437838_m1

Software, algorithm

Imaris

Bitplane,
South Windsor, CT

RRID:SCR_007370

Version 9, used for
image analysis.

Software, algorithm

Prizm

GraphPad
Software, LLC.

RRID:SCR_002798

Version 8.3.0

Mice
Nr1d1+/-mice on C57bl/6 background were obtained from The Jackson Laboratory (Bar Harbor, ME)
and bred at at Washington University. Heterozygous mice were bred together to generate Nr1d1+/+
(wt) and Nr1d1-/- (referred to as REV-ERBa KO or RKO) littermates which were used for experiments.
For all experiments, a mix of male and female mice was used. No obvious difference between sexes
was noted, though experiments were not powered to detect sex differences. WT mice were C57Bl/
6J mice from Jackson Labs. Constitutive Bmal1-/- (BMKO), CAG-CreERT2, Aldh1L1-CreERT2, Cx3cr1CreERT2, and Bmal1fl/fl mice were obtained from the Jackson Laboratory, and bred so that mice were
heterozygous for Cre and homozygous for the floxed Bmal1 allele. In these experiments, Cre-;
Bmal1f/f littermates were used as controls. All inducible knockout lines were were treated with
tamoxifen (Sigma) dissolved in corn oil via oral gavage, 2.5 mg/day for 5 days, at 2mo. Camk2a-
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iCre+;Bmal1fl/fl mice were bred at University of Texas- Southwestern Medical Center. Cx3cr1GFP
mice were obtained from The Jackson Laboratory. Mice were housed on a 12/12 light/dark cycle
and fed ad libitum. All procedures performed on the mice were approved by the Washington University IACUC.

Immunohistochemistry
The following primary antibodies were used (with dilution): Gfap (Rabbit polyclonal, 1:2500, Dako/
Agilent Cat# Z0334), C3 (Rat monoclonal, 1:500, Novus Biologicals Cat# NB200-540), Iba1 (Goat
polyclonal, 1:500, Abcam Cat# ab5076), Synaptophysin (Mouse monoclonal, 1:100, Abcam Cat#
ab8049), CD68 (Rat monoclonal, 1:250, BioRad, Cat# MCA1957), Homer1 (Rabbit polyclonal, 1:500,
Synaptic Systems Cat# 160 003), Synaptoporin (Rabbit polyclonal, 1:1000, Synaptic Systems Cat#
102 002), NeuN (Mouse monoclonal, 1:1000, EMD/Millipore Cat# 14-5698-82). Specificity of all antibodies was confirmed via staining without primary antibody, and in the case of the anti-C3 antibody,
was tested in C3 KO mouse tissue.
Mice were anesthetized with intraperitoneal (i.p.) injection of pentobarbital (150 mg/kg), followed
by pump perfusion for three mins with ice cold Dulbecco’s modified Phosphate Buffered Saline
(DPBS) containing 3 g/l heparin sulfate. One hemisphere was drop fixed in 4% paraformaldehyde
(PFA) for 24 hr at 4˚C, then cryoprotected with 30% sucrose in PBS also at 4˚C for at least 48 hr.
Brains were embedded in OCT and frozen in acetone with dry ice. Twelve mm serial coronal sections
were cut on a cryostat and mounted directly onto the glass slides for synaptic pruning analysis or
synaptic quantification. Sections were washed three times in Tris buffered saline (TBS), blocked for
45 min in TBS containing 20% goat (or donkey) serum, 2% Mouse-on-mouse (M.O.M) blocking
reagent and 0.4% Triton X-100 (Sigma-Aldrich, St. Louis, MO). Sections were then incubated in TBS
containing 10% goat (or donkey) serum, 8% M.O.M protein concentrate and 0.4% Triton X-100 with
primary antibody overnight at 4˚C. Sections were then washed three times and incubated for 4 hr at
room temperature with 1:1000 fluorescent secondary antibody in a solution of TBS containing 10%
goat (or donkey) serum, 8% M.O.M protein concentrate and 0.4% Triton X-100. For other non-synaptic staining, 50 mm serial coronal sections were cut on a freezing sliding microtome and stored in
cryoprotectant (30% ethylene glycol, 15% sucrose, 15% phosphate buffer in ddH2O). Sections were
washed three times in Tris buffered saline (TBS), blocked for 30 min in TBS containing 3% goat
serum and 0.25% Triton X-100 (Sigma-Aldrich, St. Louis, MO) then incubated in TBS containing 1%
goat serum and 0.25% Triton X-100 with primary antibody overnight at 4˚C. Sections were then
washed three times and incubated for 1 hr at room temperature with 1:1000 fluorescent secondary
antibody and mounted on slides. Confocal images were taken on the Nikon Elements software on
the Nikon A1Rsi scanning confocal microscope. Z-stacks were taken at a step size of 0.5–1 mm from
dark to dark through the tissue.

Microarray analysis
Previously-published transcriptomic datasets were analyzed for expression of complement transcripts. Both datasets were from Agilent 4  44 k mouse microarrays. One dataset was derived from
5- to 6-month-old Bmal1 and REV-ERBa KO mice with WT littermate controls, and used hippocampal tissue. This dataset was previously published (Griffin et al., 2019) and is freely available on the
Array Express Server: https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-7590. The second
dataset was derived from Nestin-Cre;Bmal1f/f mice (and Cre- controls) aged to 12 months, and used
cerebral cortex tissue. This dataset was also previously published (Lananna et al., 2018) and is also
available on Array Express Server: https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-7151.
For this dataset, the samples harvested at 6pm are shown.

Quantitative PCR
Flash-frozen brain tissue was homogenized with a mechanical handheld homogenizer for 20 seconds
in RNA kit lysis buffer (PureLink RNA Mini Kit, Life Technologies, Carlsbad, CA) plus 1% b-mercaptoethanol. RNA was then purified using the kit protocol. Cells well collected and lysed in Trizol (Life
Technologies). The aqueous layer was collected following chloroform extraction (added at 1:5 then
spun at 13,000xg for 15 min) with RNA isolation protocol. RNA concentrations were then measured
using the Nanodrop spectrophotometer and cDNA was made using a high-capacity RNA-cDNA
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reverse transcription kit (Applied Biosystems/LifeTechnologies) with 1 mg RNA used per 20 mL reaction. Real-time quantitative PCR was performed with Taqman primers and PCR Master Mix buffer
(Life Technologies) on the ABI StepOnePlus 12 k Real-Time PCR thermocyclers. b-actin (Actb) mRNA
levels were used for normalization during analysis. The following primers were used (all from Life
Technologies, assay number is listed): Actb: Mm02619580_g1, Nr1d1: Mm00520708_m1, C4b:
Mm00437893_g1, C3: Mm01232779_m1, Fabp7: Mm00437838_m1.

Electron microscopy
Animals were perfused with a fixative mix consisting of 2.5% glutaraldehyde + 2% paraformaldehyde
(fresh, EM grade) in 0.15 M cacodylate buffer with 2 mM CaCl2 (final concentrations). Brains were
extracted, blocked, and 100 mm coronal sections were made using a Leica 1200S vibratome. Tissues
were then washed 3  10 min in cold cacodylate buffer containing 2 mM calcium chloride, and then
incubated in a solution of 1% OsO4 containing 3% potassium ferrocyanide in 0.3M cacodylate buffer
with 4 mM calcium chloride for 1 hr in the dark. Following incubation, tissues were incubated for 20
min in a 1% thiocarbohydrazide (TCH) solution, rinsed 3  10 min in ddH2O at room temperature
and thereafter placed in 2% osmium tetroxide (NOT osmium ferrocyanide) in ddH20 for 30 min, at
room temperature. Tissues were washed 3  10 min at room temperature in ddH2O then placed in
1% uranyl acetate (aqueous) and incubated at 4˚ overnight. Tissues were incubated in a lead aspartate solution at 60˚C oven for 30 min, washed 5  3 min in ddH2O, and returned to the lead aspartate solution at 60˚C for 30 min. Tissues were washed 3  10 min in room temperature ddH2O and
dehydrated in 50%, 70%, 90%, 100%, 100% acetone (anhydrous), 10 min each. Samples were
embedded in Durcupan ACM resin and polymerized 60˚C oven for 48 hr. Seventy nm slices were
made using a Leica UC7 ultramicrotome, and sections were picked up on a Si wafer (Ted Pella,
Redding, CA). Images were acquired on a Zeiss Merlin FE-SEM using a solid state backscatter detector (8kV, 900 pA) at 7 nm resolution with 5 ms pixel dwell times and 4x line averaging. Large area
scans of ~150 mm x 150 mm field of view were acquired and stitched using Atlas 5.0 (Fibics, Ottawa,
Canada).

Stereotactic surgery and intracortical viral injections
Stereotactic viral vector injections were performed on Cx3cr1GFP mice. Briefly, mice were anesthetized with inhaled isoflurane, the head was shaved and the skull exposed and cleaned with iodine,
and the head supported in ear bars. A hole was drilled through the skull. The coordinates used for
the retrospenial cortex were 0.3 mm mediolateral (M/L), 2 mm anterior-posterior(A/P) and 1 mm
dorso-ventral(D/V) with bregma as a reference. The needle was placed in the target location and
then allowed to rest for 2 min before infusion. The AAV2-Camk2a-mCherry virus was obtained from
the UNC viral vector core and infused at a rate of 0.2 mL/min. In total, the mice were injected with 2
mL in the retrospenial cortex. After the infusion, we waited 5 min for the virus to diffuse in the parenchyma and then the needle was slowly removed. The skin over the skull was then stitched up and
antibiotic was applied to the area. The mice were then allowed to recover in an empty cage on a
heating pad. After the surgery the mice were checked twice daily, 4 hr apart to ensure survival for 3
days. The mice were then allowed to age for 1 month before being sacrificed for sectioning and
imaging.

Synaptic volume and engulfment analysis/3D reconstructions
Imaris visualization and analysis software (Version 9, Bitplane, South Windsor, CT, USA) was used at
the Washington University Center for Cellular Imaging. For all analyses, Z-stacks were saved in the.
nd2 file format and loaded into the software. 3-D surfaces had a surface detail ranging from 0.1 to
0.3 mm. To quantify the volume of the synapses, we generated 3-D surfaces from each of the synaptic markers (Synaptophysin, Synaptoporin and Homer1). We used the Batch colocalization function
to colocalize the Synaptophysin and Homer1 volumes. The total volume for each Z-stack was
summed. For the synaptic engulfment analyses, we first generated volumes from synaptophysin,
CD68 and Iba1 staining. We then colocalized the synaptophysin volume with the CD68 volume. The
resulting volume was then colocalized with the Iba1 volume to produce a final microglial synaptic
engulfment volume. All values were normalized to the average values for the control group in each
experiment.
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Primary neuronal cultures
Neuronal cultures were made from age E18 Bmal1f/f mouse pups. Cortices plus hippocampi were
dissected and stripped of meninges in ice-cold DMEM (Life Technologies) and then incubated in
0.05% Trypsin-EDTA at 37˚C for 15 min. Tissue was gently triturated in 37˚C DMEM plus 10% FBS
(Gibco). Triturated cells were transferred to a second tube to remove debris, then diluted in Neurobasal (Life Technologies) plus B27 (Life Technologies) prior to plating on a PDL-coated plates. Cells
were treated with 1 uM cytosine arabinoside for 24 hr, after which media was replaced. On DIV 4,
Bmal1f/f neuron-enriched cultures were treated with either AAV8-CMV-GFP or AAV8-CMV-Cre for 4
days. Media was then again changed, and cells were harvested for in Trizol reagent at DIV 10.

Statistical analysis
Statistical analyses were performed using GraphPad Prism 8. We performed t-tests with Welch’s correction for multiple comparisons.
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